Issued Patents All Time
Showing 1–25 of 96 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12358931 | 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor | Ryan Hudson, Jennifer Kozak, Paul R. Fatheree, Dante D. Podesto, Gary E. L. Brandt +1 more | 2025-07-15 |
| 12351561 | Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof | Adam D. Hughes, Miroslav Rapta, Venkat R. Thalladi, R. Michael Baldwin, David L. Bourdet | 2025-07-08 |
| 12016835 | Neprilysin inhibitors | Adam D. Hughes, Erik Fenster, Roland Gendron, Edmund J. Moran | 2024-06-25 |
| 11919888 | Neprilysin inhibitors | Adam D. Hughes | 2024-03-05 |
| 11851443 | Neprilysin inhibitors | Roland Gendron, Adam D. Hughes | 2023-12-26 |
| 11718591 | Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof | Adam D. Hughes, Miroslav Rapta, Venkat R. Thalladi, Gene Timothy Fass, Michael Simeone +2 more | 2023-08-08 |
| 11718616 | JAK kinase inhibitor compounds for treatment of respiratory disease | Paul R. Fatheree, John R. Jacobsen, Anne-Marie Beausoleil, Gary E. L. Brandt, Lan Jiang +9 more | 2023-08-08 |
| 11642332 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta | 2023-05-09 |
| 11634413 | Neprilysin inhibitors | Adam D. Hughes | 2023-04-25 |
| 11547687 | Neprilysin inhibitors | Adam D. Hughes, Erik Fenster, Roland Gendron, Edmund J. Moran | 2023-01-10 |
| 11299492 | JAK kinase inhibitor compounds for treatment of respiratory disease | Paul R. Fatheree, John R. Jacobsen, Gary E. L. Brandt, Lan Jiang, Cameron Smith +3 more | 2022-04-12 |
| 11261197 | Neprilysin inhibitors | Roland Gendron, Adam D. Hughes | 2022-03-01 |
| 11230536 | Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof | Adam D. Hughes, Miroslav Rapta, Venkat R. Thalladi | 2022-01-25 |
| 11174219 | Neprilysin inhibitors | Adam D. Hughes | 2021-11-16 |
| 11130759 | 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors | Muzaffar Alam, Leah Cleary, Zhonghua Pei, Richard Steel, James Sutton +2 more | 2021-09-28 |
| 11124502 | Neprilysin inhibitors | Adam D. Hughes | 2021-09-21 |
| 11110095 | Pyrimidine compounds as JAK kinase inhibitors | Ryan Hudson, Jennifer Kozak, Paul R. Fatheree, Anne-Marie Beausoleil, Dante D. Podesto +1 more | 2021-09-07 |
| 11084798 | 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors | Muzaffar Alam, Leah Cleary, Zhonghua Pei, Richard Steel, James Sutton +2 more | 2021-08-10 |
| 11046691 | 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors | Muzaffar Alam, Leah Cleary, Zhonghua Pei, Richard Steel, James Sutton +2 more | 2021-06-29 |
| 11033533 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta | 2021-06-15 |
| 10836744 | Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity | Adam D. Hughes, Daniel H. Byun, Yan Chen, John R. Jacobsen, Eric L. Stangeland +2 more | 2020-11-17 |
| 10829438 | Neprilysin inhibitors | Adam D. Hughes | 2020-11-10 |
| 10752599 | Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof | Adam D. Hughes, Miroslav Rapta, Venkat R. Thalladi, Gene Timothy Fass, Michael Simeone | 2020-08-25 |
| 10744104 | Neprilysin inhibitors | Adam D. Hughes, Erik Fenster, Roland Gendron, Edmund J. Moran | 2020-08-18 |
| 10590107 | Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity | Adam D. Hughes, Daniel H. Byun, Yan Chen, John R. Jacobsen, Eric L. Stangeland +2 more | 2020-03-17 |